| Abstract Number | Presenting Author | Title |
| Topic: Chrono-Matrix |
| 1 | Amanda Oliveira | A Weight Loss-Specific Fibrotic Response in Visceral Fat Is Driven by Defective Lysosome-Dependent Collagenolysis |
| Topic: Immuno-Matrix |
| 2 | Guilhem Graveron | Uncovering endogenous pro-resolving immune-stromal programs in skin fibrosis |
| 3 | Marie Piollet | Neutrophil terminal programming in the ischemic heart drives fibrosis after myocardial infarction |
| 4 | Nicolas Perrard | Generation, viability assessment and fibrotic transformation of a novel organotypic model for cutaneous fibrosis: basis for therapeutic optimisation in systemic sclerosis |
| Topic: Interorgan Fibrosis |
| 5 | Li Luo | Molecular Mechanisms Linking the Fibrotic Microenvironment to Lung Cancer Development in Idiopathic Pulmonary Fibrosis |
| 6 | Guerroumi As-sakina | Development and Characterization of Precision-Cut Mesenteric Adipose Tissue Slices as an Organotypic Model for Intestinal Fibrosis |
| Topic: Imaging Matrix |
| 7 | Laura Chastagnier | Innovative Nanobody-based Approaches to Diagnose and Treat Collagen Deposition in Fibrotic Disorders through PCPE1 Targeting |
| Topic: FibroMarkers |
| 8 | Méline Ricol | Investigating collagen I biosynthesis: molecular pathways and microenvironmental influences |
| 9 | Salomé Patry | Beyond crystalline silica: Engineered Stone (ES) exposure drives lung inflammation and fibrosis in 129/Sv Mice |
| 10 | Baptiste Rigoux | Legumain (asparaginyl endopeptidase) and cathepsin V participate in matrix remodeling during lung fibrosis |
| 11 | Lise Ratel | Effect of recombinant IL-33 on EMT process in colon and ileum human organoids |
| 12 | Mathilde Leboutte | The mineralocorticoid receptor in smooth muscle cells modulates gut barrier function in mice and human colonic organoids: does this predispose for intestinal fibrosis? |
| 13 | Elise Rebollo | Neutrophil Gelatinase Associated Lipocalin (NGAL) invalidation in myeloid cells did not improve inflammation but reduced fibrosis in mice with colitis |
| 14 | Sara Al Issa | Characterization of a transcriptomic signature associated to septin cytoskeleton relocalization in response to various stresses : study of its possible function in early fibrosis. |
| 15 | Léna E Silva | Lipidomics of extracellular vesicles from bronchoalveolar lavage identifies new target for pulmonary fibrosis |
| 16 | Divya Prabhakar Reddy | Modulation of proteoglycans expression in a bleomycin-induced pulmonary fibrosis model in mice |
| 17 | Wenrui Gao | Identification of Sfrp1 in portal fibroblasts and impact on biliary fibrosis development |
| 18 | Zhenyi Zhao | Assessing the effects of Nicotinamide Riboside (NR) combined with exercise training in heart failure with preserved ejection fraction |
| 19 | Perrine Singla | Patient-Derived Organoids Identify Epithelial Mechanisms Underlying Fibrosis in Endometriosis |
| 20 | Laura Muraine | Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies |
| 21 | Mariana Amaral Raposo | Promoter-Driven Depletion of Fibrogenic Cells as a Therapeutic Strategy for Liver fibrosis |
| Topic: Preclinical Matrix |
| 22 | Maéva Loriot | New therapeutic targets for hepatic fibrosis in MASLD: the SGLT2 cotransporter and the cannabinoid-1 receptor |
| 23 | Maria Bergas Buades | Modeling Fibrosis in Oculopharyngeal Muscular Dystrophy using engineered 3D human Skeletal Muscle |
| 24 | Mariia Pestriakova | Exploring the Antifibrotic Potential of the Heparan Sulfate Mimetic OTR4132 on Validated Human Precision-Cut Lung Slices (hPCLS) Model Mimicking Pulmonary Diseases |
| 25 | Karim Tazibet | Development of mouse and pig models of pulmonary fibrosis and gene inhibition testing of potential therapeutic targets |
| 26 | Florent Morfoisse | Role of Lysyl Oxidase in the pathological interplay between extracellular matrix and lymphatics in secondary lymphedema |
| 27 | Stefano Biressi | Reduced fibrosis after in vivo inhibition of complement C1 in Duchenne Muscular Dystrophy |
